Infiltrating lobular carcinoma: Is it different from infiltrating duct carcinoma?

Background. Infiltrating lobular carcinomas (ILC) represent approximately 10% of all breast cancers. The literature is mixed regarding their prognosis when compared with infiltrating duct carcinomas (IDC). There are few data regarding the treatment of ILC with radiation therapy. Methods. The clinical, pathologic, laboratory, and survival data of 161 patients with ILC were compared with the data of 1138 patients with IDC. Results. ILCs were larger, more difficult to excise completely, and more difficult to diagnose clinically. All prognostic factors measured were more favorable for ILC Nodal positivity for ILC was 32%, compared with 37% for IDC (P = 0.22). The 7-year disease-free Kaplan-Meier survival (DFS) was 74% for patients with ILC and 63% for patients with IDC (P < 0.03). The 7-year breast cancer specific survival (BCSS) was 83% for patients with ILC and 77% for patients with IDC (P < 0.04). Selected patients with smaller lesions were treated with excison and radiation therapy. Patients with ILC treated with radiation therapy had a better DFS and BCSS than did patients with IDC treated with radiation therapy. Conclusions. ILCs often are homogeneous, small cell tumors of low nuclear grade. Their desmoplastic reaction may be absent or less marked than that of IDC, making them more difficult to palpate and to visualize mammographically. Despite this, they can be treated successfully with either mastectomy or excision and radiation therapy.

[1]  F. W. Foote,et al.  A histologic classification of carcinoma of the breast. , 1946, Surgery.

[2]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[3]  W. Newman.  Lobular Carcinoma of the Female Breast: Report of 73 Cases , 1966, Annals of surgery.

[4]  J. Urban,et al.  Selecting variations in extent of surgical procedure for breast cancer , 1971, Cancer.

[5]  A. Huvos,et al.  Infiltrating lobular carcinoma of the breast , 1973, Cancer.

[6]  R. Fechner.  Histologic variants of infiltrating lobular carcinoma of the breast. , 1975, Human pathology.

[7]  C. Redmond,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer , 1975, Cancer.

[8]  R. Tarone,et al.  A Study of Lobular Carcinoma of the Breast Based on the Third National Cancer Survey in the United States of America , 1979, Tumori.

[9]  J. Azzopardi,et al.  Invasive lobular carcinoma of the breast: incidence and variants , 1979, Histopathology.

[10]  R. P. Davis,et al.  Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management. , 1979, Archives of surgery.

[11]  A. Luini,et al.  Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast , 1981 .

[12]  M. Lesser,et al.  Multicentricity and bilaterality in invasive breast carcinoma. , 1982, Surgery.

[13]  D. Page,et al.  Infiltrating lobular carcinoma of the breast , 1982, Histopathology.

[14]  S. Duffy,et al.  Infiltrating lobular carcinoma of the breast: An evaluation of the incidence and consequence of bilateral disease , 1983, The British journal of surgery.

[15]  A. Howell,et al.  A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. , 1984, British Journal of Cancer.

[16]  B Fisher,et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.

[17]  Multicentricity in nonpalpable breast carcinoma and its implications for treatment. , 1986, American journal of surgery.

[18]  T. Mate,et al.  A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma , 1986, Cancer.

[19]  A. Howell,et al.  Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. , 1987, European journal of cancer & clinical oncology.

[20]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[21]  J. Torhorst,et al.  Conservation therapy for breast cancers other than infiltrating ductal carcinoma , 1989, Cancer.

[22]  S. Schnitt,et al.  Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy , 1989, Cancer.

[23]  I. Gareen,et al.  Prognosis in Infiltrating Lobular Carcinoma: An Analysis of “Classical” and Variant Tumors , 1990, The American journal of surgical pathology.

[24]  H. Peterse,et al.  The spectrum of gastrointestinal metastases of breast carcinoma: II. The colon and rectum. , 1992, Gastrointestinal endoscopy.

[25]  H. Peterse,et al.  The spectrum of gastrointestinal metastases of breast carcinoma: I. Stomach. , 1992, Gastrointestinal endoscopy.

[26]  A. Giuliano,et al.  Conservation therapy for invasive lobular carcinoma of the breast , 1992, Cancer.

[27]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[28]  M. Borst,et al.  Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. , 1993, Surgery.